Â

| Parameter |
Definition |
Information |
| Clotting Time CT (sec) |
Time to reach 2mm amplitude from beginning of test |
Speed of fibrin formation; influenced by clotting factors, anti-coagulants |
| Clot Formation Time CFT (sec) |
Time to reach 20mm amplitude from the time of 2mm amplitude |
Kinetics of clot formation; influenced by platelet level / function and fibrinogen level / ability to polymerize |
| Maximum Clot Firmness, MCF |
Maximum amplitude (in mm) |
Firmness of clot, i.e., clot quality; influenced by platelets, fibrinogen (concentration and ability to polymerize), Factor XIII, fibrinolysis |
| Maximum Lysis, ML (% of MCF) |
Percent of clot firmess lost during measurement |
Abnormal ML at 30 minutes likely indicates fibrinolysis |
|
Â
ROTEM® Analysis
ROTEM® provides the most complete and rapid information on hemostasis. Unlike other clotting assays, ROTEM® analyzes whole blood and provides infomation about all stages of the coagulation process.
ROTEM® tests capture specific paramaeters (described more fully at left) that provide information about the elements affecting hemostasis.
The results of the ROTEM® analysis should not be the sole basis for a patient diagnosis, but should be evaluated together with the patient's medical history (anamnesis), the clinical picture and, if necessary, further coagulation tests.
|